Author:
Kadokura Takeshi,den Adel Martin,Krauwinkel Walter J. J.,Takeshige Tetsuo,Nishida Akito
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference18 articles.
1. Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA (2002) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterol 119:654–660
2. Gershon MD (1999) Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 13(Suppl 2):15–30
3. Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J (1998) Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 12:849–855
4. Forster JM, Houghton LA, Whorwell PJ (1997) Alosetron shows colonic transit in patients with irritable bowel syndrome (IBS). Gastroenterol 112:A732. (Abstract)
5. Northcutt AR, Camilleri M, Mayer EA et al (1998) Alosetron, a 5HT3-receptor antagonist, is effective in the treatment of female irritable bowel syndrome patients. Gastroenterol 114:A812. (Abstract)
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献